Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome

Fertility and Sterility

Volumn 67, Issue 2, 1997, Pages 261-265

  Abramov, Yoram ^a,b   Barak, Vivian ^a   Nisman, Benjamin ^a   Schenker, Joseph G ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Ascites; ovarian hyperstimulation syndrome; vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ADULT; ARTICLE; ASCITES; BLOOD VESSEL PERMEABILITY; CELL SPECIFICITY; DRUG BLOOD LEVEL; FEMALE; HEMOCONCENTRATION; HUMAN; HUMAN EXPERIMENT; MITOGENICITY; NORMAL HUMAN; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PARACENTESIS; PRIORITY JOURNAL;

EID: 0031019390     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)81908-5     Document Type: Article

References (12)

1. Schenker JG, Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil Steril 1978;30:255-68.
2. Polishuk WZ, Schenker JG. Ovarian overstimulation syndrome. Fertil Steril 1969;20:443-50.
3. Ferrara N, Houck K, Jakeman LB, Winer J, Leung DW. The vascular endothelial growth factor family of polypeptides. J Cell Biol 1991;47:211-8.
4. Abramov Y, Schenker JG, Lewin A, Friedler S, Nisman B, Barak V. Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. Hum Reprod 1996; 11:1381-6.
5. Revel A, Barak V, Lavy Y, Anteby E, Abramov Y, Schenker JG, et al. Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome. Fertil Steril 1996;66:66-71.
6. McClure N, Healy DL, Rogers PAW, Sullivan J, Beaton L, Haning RV Jr, et al. Vascular endothelial growth factor as a capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 1994;344:235-6.
7. Robertson D, Selleck K, Suikkari A, Hurley V, Moohan J, Healy D. Urinary vascular endothelial growth factor concentrations in women undergoing gonadotropin treatment. Hum Reprod 1995; 10:2478-82.
8. Neulen J, Yan Z, Raczek S, Weindel K, Keck C, Weich HA, et al. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 1995;80: 1967-71.
9. Krasnow JS, Berga SL, Guzick DS, Zeleznik AJ, Yeo K-T. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil Steril 1996;65:552-5.
10. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992;58:249-61.
11. Ferrara N, Houck K, Jakeman L, Leung D Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13:18-32.
12. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219:983-5.